Repligen (RGEN) Misses Q2 EPS by 2c; offers guidance
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $180.71 +2.16%
EPS Growth %: 0.0%
Financial Fact:
(Loss) income from operations: 3.75M
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: 0.0%
Financial Fact:
(Loss) income from operations: 3.75M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.37, $0.02 worse than the analyst estimate of $0.39. Revenue for the quarter came in at $182 million versus the consensus estimate of $175.35 million.
GUIDANCE:
Repligen sees FY2025 EPS of $1.65-$1.72, versus the consensus of $1.68. Repligen sees FY2025 revenue of $715-735 million, versus the consensus of $710.2 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GameStop CEO Cohen buys 1.15M shares
- CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk
- Jefferies Starts W. P. Carey & Co. (WPC) at Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
